Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V98.2.343PMID 11435302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-kit mutations in core binding factor leukemias.

  2000cited by this paper
• Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products.

  2000cited by this paper
• Point mutation in Kit receptor tyrosine kinase reveals essential roles for Kit signaling in spermatogenesis and oogenesis without affecting other Kit responses

  2000cited by this paper
• Impaired Kit- but Not FcεRI-initiated Mast Cell Activation in the Absence of Phosphoinositide 3-Kinase p85α Gene Products*

  2000cited by this paper
• Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

  1999cited by this paper
• Signaling via Src family kinases is required for normal internalization of the receptor c-Kit.

  1999cited by this paper
• Early signaling pathways activated by c-Kit in hematopoietic cells.

  1999cited by this paper
• The biology of stem cell factor and its receptor C-kit.

  1999cited by this paper
• Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells.

  1999cited by this paper
• Genetic evidence for Lyn as a negative regulator of IL-4 signaling.

  1999cited by this paper
• Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth

  1999cited by this paper
• CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.

  1999cited by this paper
• Independent and Opposing Roles For Btk and Lyn in B and Myeloid Signaling Pathways

  1998cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• Requirement of Src Kinase Lyn for Induction of DNA Synthesis by Granulocyte Colony-stimulating Factor*

  1998cited by this paper
• Kit signaling through PI 3‐kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

  1998cited by this paper
• A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals

  1998cited by this paper
• Stem cell factor and hematopoiesis.

  1997cited by this paper
• Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

  1997cited by this paper
• Mast cells.

  1997cited by this paper
• Direct Association of Csk Homologous Kinase (CHK) with the Diphosphorylated Site Tyr568/570 of the Activated c-KIT in Megakaryocytes*

  1997cited by this paper
• IgE Enhances Mouse Mast Cell FcεRI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions

  1997cited by this paper
• Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells.

  1997cited by this paper
• Lyn Associates with the Juxtamembrane Region of c-Kit and Is Activated by Stem Cell Factor in Hematopoietic Cell Lines and Normal Progenitor Cells*

  1997cited by this paper
• Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1

  1996cited by this paper
• Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice

  1996cited by this paper
• Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.

  1996cited by this paper
• Differential roles of PI3‐kinase and Kit tyrosine 821 in Kit receptor‐mediated proliferation, survival and cell adhesion in mast cells.

  1995cited by this paper
• Receptor tyrosine kinases and the regulation of hematopoiesis.

  1995cited by this paper
• Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease.

  1995cited by this paper
• Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

  1995cited by this paper
• Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.

  1995cited by this paper
• The kit ligand, stem cell factor.

  1994cited by this paper
• Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.

  1994cited by this paper
• Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C.

  1994cited by this paper
• The hematopoietin receptor superfamily.

  1993cited by this paper
• Steel factor and c‐Kit receptor: From mutants to a growth factor system

  1993cited by this paper
• From white spots to stem cells: the role of the Kit receptor in mammalian development.

  1993cited by this paper
• The yes-related cellular gene lyn encodes a possible tyrosine kinase similar to p56lck

  1987cited by this paper

• Targeting SET to counteract Lyn activation demonstrates anti-cancer potential in diffuse large B-cell lymphoma

  2025cites this paper
• Multi-omics analysis revealed the dysfunction of ovary and testis induced by chronic hypoxia in Pelteobagrus fulvidraco

  2024cites this paper
• Crosstalk between Lipid Rafts and Aging: New Frontiers for Delaying Aging

  2022cites this paper
• c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer

  2021cites this paper
• SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis

  2020cites this paper
• SCF promotes the production of IL-13 via the MEK-ERK-CREB signaling pathway in mast cells

  2019cites this paper
• Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks

  2019cites this paper
• Oxidant Signaling Mediated by Nox2 in Neutrophils Promotes Regenerative Myelopoiesis and Tissue Recovery following Ischemic Damage

  2018cites this paper
• Adhesion structures in leukemia cells and their regulation by Src family kinases

  2018cites this paper
• Genotoxic stress induces Sca‐1‐expressing metastatic mammary cancer cells

  2018cites this paper
• The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer

  2017cites this paper
• DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway

  2017cites this paper
• Essential Role of Lyn in Fibrosis

  2016cites this paper
• Signal transduction and chemotaxis in mast cells.

  2016cites this paper
• The PDGFR Receptor Family

  2015cites this paper
• Receptor Tyrosine Kinases: Family and Subfamilies

  2015cites this paper
• Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice

  2014cites this paper
• SHP2 Phosphatase Promotes Mast Cell Chemotaxis toward Stem Cell Factor via Enhancing Activation of the Lyn/Vav/Rac Signaling Axis

  2014cites this paper
• Molecular defects in mastocytosis: KIT and beyond KIT.

  2014cites this paper
• This information is current as Signaling Axis Enhancing Activation of the Lyn / Vav / Rac Chemotaxis toward Stem Cell Factor via SHP 2 Phosphatase Promotes Mast Cell

  2014cites this paper
• Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

  2014cites this paper
• Targeting mast cells in inflammatory diseases.

  2014cites this paper
• Signaling Axis Enhancing Activation of the Lyn/Vav/Rac Chemotaxis toward Stem Cell Factor via SHP2 Phosphatase Promotes Mast Cell

  2014cites this paper
• integrin LFA-1 in leukemia cells 2 β mediated adhesive responses through the - α BCR-ABL1 alters SDF-1

  2013cites this paper
• SHP2/PTPN11 PROTEIN-TYROSINE PHOSPHATASE PROMOTES MAST CELL HOMEOSTASIS AND SYSTEMIC MASTOCYTOSIS

  2013cites this paper
• A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo

  2013cites this paper
• Calcineurin–Rcan1 Interaction Contributes to Stem Cell Factor–Mediated Mast Cell Activation

  2013cites this paper
• This information is current as Activation Mediated Mast Cell − to Stem Cell Factor Rcan 1 Interaction Contributes − Calcineurin Junkins

  2013cites this paper
• In vivo knockdown of ckit impairs neuronal migration and axonal extension in the cerebral cortex

  2013cites this paper
• kinase in cultured human airway smooth muscle cells Expression and muscarinic receptor coupling of Lyn

  2013cites this paper
• Stem cell factor receptor/c-Kit: from basic science to clinical implications.

  2012cites this paper
• FES/FER kinase signaling in hematopoietic cells and leukemias.

  2012cites this paper
• Identification of key kinases associated with bone marrow toxicity

  2011cites this paper
• The non-receptor tyrosine kinase Lyn controls neutrophil adhesion by recruiting the CrkL–C3G complex and activating Rap1 at the leading edge

  2011cites this paper
• Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival

  2011cites this paper
• The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms

  2011cites this paper
• Association of Src-Related Kinase Lyn with the Interleukin-2 Receptor and Its Role in Maintaining Constitutive Phosphorylation of JAK/STAT in Human T-Cell Leukemia Virus Type 1-Transformed T Cells

  2011cites this paper
• Molecular mechanisms of signal transduction in neutrophil chemotaxis

  2011cites this paper
• Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line

  2011cites this paper
• Investigating a co-operative link between TGF-β and Lyn kinase in Chronic Myeloid Leukaemia

  2011cites this paper
• Balanced Interactions between Lyn, the p85α Regulatory Subunit of Class IA Phosphatidylinositol-3-Kinase, and SHIP Are Essential for Mast Cell Growth and Maturation

  2011cites this paper
• and Other Genes Associated with the Center-Associated Nuclear Protein B Cells Reveals Germinal Microarray Analysis of Lyn-Deficient

  2010cites this paper
• Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.

  2010cites this paper
• Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

  2010cites this paper
• CD72 Negatively Regulates KIT-Mediated Responses in Human Mast Cells

  2010cites this paper
• Comparative transcriptional profiling of the limbal epithelial crypt demonstrates its putative stem cell niche characteristics

  2010cites this paper
• Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.

  2009cites this paper
• Multiple roles of Lyn kinase in myeloid cell signaling and function

  2009influential citation
• FPS/FES KINASE REGULATES CYTOSKELETAL REORGANIZATION AND MIGRATION OF MAST CELLS

  2009cites this paper
• Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1.

  2009cites this paper
• The tyrosine kinase network regulating mast cell activation

  2009cites this paper
• BCR-ABL1 alters SDF-1alpha-mediated adhesive responses through the beta2 integrin LFA-1 in leukemia cells.

  2008cites this paper
• Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.

  2008cites this paper
• Dual acylation and lipid raft association of Src‐family protein tyrosine kinases are required for SDF‐1/CXCL12‐mediated chemotaxis in the Jurkat human T cell lymphoma cell line

  2008cites this paper
• The Early Growth Response Factor-1 Contributes to Interleukin-13 Production by Mast Cells in Response to Stem Cell Factor Stimulation

  2008cites this paper
• Protein-tyrosine Phosphatase α Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells*

  2008cites this paper
• Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.

  2008cites this paper
• Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK

  2008cites this paper
• Regulation of phagocyte migration and recruitment by Src-family kinases

  2008cites this paper
• The Early Growth Response Factor-1 Is Involved in Stem Cell Factor (SCF)-induced Interleukin 13 Production by Mast Cells, but Is Dispensable for SCF-dependent Mast Cell Growth*

  2007cites this paper
• The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

  2007cites this paper
• Lipid rafts are required for Kit survival and proliferation signals.

  2007cites this paper
• Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells.

  2007cites this paper
• BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?

  2007cites this paper
• Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.

  2007cites this paper
• The inhibitory effect of Houttuynia cordata extract on stem cell factor-induced HMC-1 cell migration.

  2007cites this paper
• Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis.

  2006cites this paper
• Treatment of diffuse large B-cell lymphoma: a risk-based approach.

  2006cites this paper
• Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.

  2006cites this paper
• Stem Cell c-KIT and HOXB4 Genes: Critical Roles and Mechanisms in Self-Renewal, Proliferation, and Differentiation

  2006cites this paper
• Stem cell factor expression, mast cells and inflammation in asthma

  2006cites this paper
• CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.

  2006cites this paper
• The stem cell factor receptor/c-Kit as a drug target in cancer.

  2006cites this paper
• Lyn kinase promotes erythroblast expansion and late-stage development.

  2006cites this paper
• Expression and muscarinic receptor coupling of Lyn kinase in cultured human airway smooth muscle cells.

  2006cites this paper
• The case for rituximab in AIDS-related lymphoma.

  2006cites this paper
• Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.

  2006cites this paper
• Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.

  2006cites this paper
• The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling

  2006cites this paper
• Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.

  2005cites this paper
• Two different pathways link G-protein-coupled receptors with tyrosine kinases for the modulation of growth and survival in human hematopoietic progenitor cells.

  2005cites this paper
• Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.

  2005cites this paper
• KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.

  2005cites this paper
• Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.

  2005cites this paper
• Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit

  2005cites this paper
• Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.

  2005cites this paper
• C-Kit signal transduction and involvement in cancer

  2005cites this paper
• Src kinases and Flt3: phosphorylation, interference with receptor maturation and mechanism of association

  2005cites this paper
• Signal transduction via the stem cell factor receptor/c-Kit

  2004cites this paper
• Regulation of Apoptosis in Hematopoietic Progenitor Cells: Involvement of Different Signaling Pathways

  2004cites this paper
• The Src kinase Lyn is a negative regulator of mast cell proliferation

  2004cites this paper
• Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.

  2004cites this paper
• Lymphoid Germinal Center Protein and Other Genes Associated with the Reveals Germinal Center-Associated Nuclear Microarray Analysis of Lyn-Deficient B Cells

  2004cites this paper
• Stem cell factor and H2O2 induce GLUT1 translocation in M07e cells

  2004cites this paper
• aggregation ε leading to human mast cell degranulation following Kit activation and Fc NTAL phosphorylation is a pivotal link between the signaling cascades

  2004cites this paper
• Microarray Analysis of Lyn-Deficient B Cells Reveals Germinal Center-Associated Nuclear Protein and Other Genes Associated with the Lymphoid Germinal Center1

  2004cites this paper
• Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells.

  2004cites this paper
• JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor.

  2004cites this paper
• Dysregulated FcεRI Signaling and Altered Fyn and SHIP Activities in Lyn-Deficient Mast Cells1

  2004cites this paper
• NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation.

  2004cites this paper